B-type natriuretic peptide (BNP) has been reported to be released from the myocardium
during ischemia. We hypothesized that BNP mediates cardioprotection during ischemia …

Natriuretic peptides are regulatory autacoids in the mammalian myocardium whose
functions, mediated via particulate guanylyl cyclase/cGMP, may include cytoprotection …

In both experimental and clinical myocardial ischaemia, release of BNP occurs rapidly from
ventricular myocardium, prompting speculation that the early activation of the natriuretic …

B-type natriuretic peptide (BNP) is a peptide hormone of myocardial origin with significant
cardioprotective properties. Patients with myocardial ischemia present with high levels of …

We investigated whether atrial natriuretic peptide (ANP) given just prior to reperfusion
reduces infarction in rabbit hearts and whether protection is related to activation of protein …

Background We have demonstrated that brain natriuretic peptide (BNP) is a cardiac
hormone predominantly synthesized in and secreted from the ventricle. We have also …

Objectives: The aim of this study was to determine the effect of transient myocardial ischemia
on circulating natriuretic peptide levels. Background: Natriuretic peptides are released by …

Background: Natriuretic peptides have actions likely to ameliorate cardiac dysfunction. B-
type natriuretic peptide (BNP) is indicated as treatment for decompensated cardiac failure …

Brain natriuretic peptide (BNP), a hormone secreted predominantly in ventricular myocytes,
may influence coronary vascular tone. We studied the coronary vasodilatory response to …

BACKGROUND: Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate
cyclase, has been found to protect against reoxygenation-induced hypercontracture in …